Introducing Sun Shield Mineral

Pop quiz: Do you know what the difference is between a physical sunscreen and a chemical sunscreen?
If your answer is that physical sunscreens protect your skin from the sun by deflecting or scattering the sun’s rays, while chemical sunscreens work by absorbing them, you are right!

How Sun Shield Mineral Benefits You
This sunscreen was recommended by the Skin Cancer Foundation as an effective broad spectrum sunscreen and can be worn every day. Because of the ingredients used in all-physical sunscreens, some formulations tend to leave a white film on the skin after application and are harder to rub into the skin. Sun Shield Mineral uses the revolutionary INVISIBLE ZINC technology, which is naturally sourced and results in a uniquely dry, clear finish.1

And if that’s not enough, here are even more of the benefits you can enjoy! Sun Shield Mineral:

Is recommended by the Skin Cancer Foundation as an effective broad spectrum sunscreen

The 7 Smart Habits for Sun Protection
You might think October is an interesting time to launch a sunscreen product, but it’s not – and let us tell you why. Because the sun’s rays can reach you through fog, windows, even the snow – you should wear sunscreen every day of the year. In addition, here are 7 Smart Habits for Sun Protection3,7 to also employ:

Seek the shade, particularly between the hours of 10am and 4pm

Avoid tanning booths

Cover up with clothing, a broad-brimmed hat, and UV-blocking sunglasses

Use a broad-spectrum sunscreen every day with an SPF of 30 or higher

Apply 1 ounce (2 tablespoons) of sunscreen all over the body 30 minutes before going outside; reapply every 2 hours, and after swimming or sweating

Every month, examine the skin head to toe for changes

Every year, visit a physician for a complete skin exam

Do you have other tips about good sun protection habits, or questions about Obagi sun protection products? Visit us on Facebook!

®/TMs are trademarks of Valeant Pharmaceuticals International, Inc., or its affiliates. Any other product or brand names and logos are the property of their respective owners. Distributed by Obagi Medical, a division of Valeant Pharmaceuticals North America LLC.

Find Obagi Products

Sign up to receive exclusive emails for first-look access to new Obagi products, expert skin care tips and advice, special promotions, and more!

All fields required

First Name *

Email *

Are you a U.S. Resident? *

Yes

No

Zip Code *

Obagi will never sell, rent, or share your personal information with any third parties for marketing purposes without your express permission. By submitting your information, you confirm you have read and agree with the terms of our Privacy Policy.

Stay Connected With Obagi

Obagi Premier Points®

Earn points every time you purchase participating Obagi products from your physician. Join today and redeem accumulated points for free Obagi products in the future. Terms and conditions apply. Download the app to see full terms and conditions.

Obagi Systems and Products are physician-dispensed and should be used only under the guidance of your skin care physician. Please be advised that certain products have limited distribution and may not be available in your area. Please contact your Obagi skin care physician for more information.

Important Safety Information for Obagi Nu-Derm Clear and Blender®

(contains 4% hydroquinone)

CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.